{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:26:14Z","timestamp":1777299974635,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00415-005-1105-4","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T20:55:54Z","timestamp":1118868954000},"page":"i19-i25","source":"Crossref","is-referenced-by-count":63,"title":["The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies"],"prefix":"10.1007","volume":"252","author":[{"given":"Marinos C.","family":"Dalakas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1105_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm0296-148","volume":"2","author":"Ellis","year":"1996","unstructured":"Ellis MT, Atkinson AM (1996) The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nature Medicine 2:148\u2013153","journal-title":"Nature Medicine"},{"key":"1105_CR2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4049\/jimmunol.156.2.818","volume":"156","author":"Daw","year":"1996","unstructured":"Daw K, Ujihara N, Atkinson M, Powers AC (1996) Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156:818\u2013825","journal-title":"J Immunol"},{"key":"1105_CR3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199005313222202","volume":"322","author":"Solimena","year":"1990","unstructured":"Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555\u20131560","journal-title":"N Engl J Med"},{"key":"1105_CR4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","volume":"55","author":"Dalakas","year":"2000","unstructured":"Dalakas MC, Fujii M, Li M, McElroy B (2000) The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55:1531\u20131535","journal-title":"Neurology"},{"key":"1105_CR5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7326\/0003-4819-131-7-199910050-00008","volume":"131","author":"Dalakas","year":"1999","unstructured":"Dalakas MC (1999) Autoantibodies and immunopathogenesis of the stiffperson syndrome. In: Levy LM moderator: The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med 131:522\u2013530","journal-title":"Ann Intern Med"},{"key":"1105_CR6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1212\/WNL.57.5.780","volume":"57","author":"Dalakas","year":"2001","unstructured":"Dalakas MC, Li M, Fujii M, Jacobowitz DM (2001) Stiff-person syndrome: quantification, specificity and intrathecal synthesis of GAD65 antibodies. Neurology 57:780\u2013785","journal-title":"Neurology"},{"key":"1105_CR7","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1212\/01.WNL.0000145661.01675.A8","volume":"63","author":"Murinson","year":"2004","unstructured":"Murinson BB, Butler M, Marfurt K, Gleason S, De Camilli P, et al. (2004) Markedly elevated GAD antibodies in SPS: effects of age and illness duration. Neurology 63:2146\u20132148","journal-title":"Neurology"},{"key":"1105_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","volume":"55","author":"Peltola","year":"2000","unstructured":"Peltola J, Kulmala P, Isojarvi J, Saiz A, Latvala K, et al. (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46\u201350","journal-title":"Neurology"},{"key":"1105_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archneur.58.2.225","volume":"58","author":"Honnorat","year":"2001","unstructured":"Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, et al. (2001) Cerebellar ataxia with antiglutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225\u2013230","journal-title":"Arch Neurol"},{"key":"1105_CR10","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1212\/01.WNL.0000145836.72059.3B","volume":"63","author":"Pearce","year":"2004","unstructured":"Pearce DA, Atkinson M, Tagle DA (2004) Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 63:2001\u20132005","journal-title":"Neurology"},{"key":"1105_CR11","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","volume":"10","author":"Vernino","year":"2004","unstructured":"Vernino S, Lennon VA (2004) Autoantibody profiles and neurological correlations of Thymoma. Clin Cancer Res 10:7270\u20137275","journal-title":"Clin Cancer Res"},{"key":"1105_CR12","first-page":"523","volume":"131","author":"Dalakas","year":"1999","unstructured":"Dalakas MC (1999) Therapeutic considerations of patients with stiff-person syndrome. In: Levy LM (moderator) The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of \u03b3-aminobutyric acid. Ann Intern Med 131:523\u2013524","journal-title":"Ann Intern Med"},{"key":"1105_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11940-003-0024-x","volume":"5","author":"Vasconcelos","year":"2003","unstructured":"Vasconcelos OM, Dalakas MC (2003) Therapies for stiff person syndrome. Curr Treat Options Neurol 5:79\u201390","journal-title":"Curr Treat Options Neurol"},{"key":"1105_CR14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jnnp.65.5.633","volume":"65","author":"Barker","year":"1998","unstructured":"Barker RA, Revesz T, Thom M, Marsden CD, Brown P (1998) Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 65:633\u2013640","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1105_CR15","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa01167","volume":"345","author":"Dalakas","year":"2001","unstructured":"Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B (2001) High-dose intravenous immunoglobulin for stiff-person syndrome. N Engl J of Med 345:1870\u20131876","journal-title":"N Engl J of Med"},{"key":"1105_CR16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00936885","volume":"242","author":"Meinck","year":"1995","unstructured":"Meinck HM, Ricker K, Hulser PJ, Solimena M (1995) Stiff man syndrome: neurophysiological findings in eight patients. J Neurol 242:134\u2013142","journal-title":"J Neurol"},{"key":"1105_CR17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410440209","volume":"44","author":"Dinkel","year":"1998","unstructured":"Dinkel K MH, Jury KM, et al. (1998) Inhibition of gama-aminoutric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 44:194\u2013201","journal-title":"Ann Neurol"},{"key":"1105_CR18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1531-8249(199908)46:2<263::AID-ANA19>3.0.CO;2-0","volume":"46","author":"Ishida","year":"1999","unstructured":"Ishida K, Mitoma H, Song Si-y, et al. (1999) An elective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 46:263\u2013267","journal-title":"Ann Neurol"},{"key":"1105_CR19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.44.9.1652","volume":"44","author":"Amato","year":"1994","unstructured":"Amato AA, Cornman EW, Kissel JT (1994) Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology 44:1652\u20131654","journal-title":"Neurology"},{"key":"1105_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jnnp.62.4.426","volume":"62","author":"Barker","year":"1997","unstructured":"Barker RA MC (1997) Successful treatment of stiff-man syndrome with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 62:426","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1105_CR21","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","volume":"291","author":"Dalakas","year":"2004","unstructured":"Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367\u20132375","journal-title":"JAMA"},{"key":"1105_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2004.04.002","volume":"102","author":"Dalakas","year":"2004","unstructured":"Dalakas MC (2004) The use of intravenous immunoglobulin in the treatment of autoimmune neurological disorders: Evidence-based indications and safety profile. Pharmacol Therapeutics 102:177\u2013193","journal-title":"Pharmacol Therapeutics"},{"key":"1105_CR23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM200104193441612","volume":"344","author":"Weinberger","year":"2001","unstructured":"Weinberger DR (2001) Anxiety at the frontier of molecular medicine. N Engl J Med 344:1247\u20131249","journal-title":"N Engl J Med"},{"key":"1105_CR24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archneur.61.6.902","volume":"61","author":"Rakocevic","year":"2004","unstructured":"Rakocevic G, Raju R, Dalakas MC (2004) Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol 61:902\u2013904","journal-title":"Arch Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-1105-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-005-1105-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-1105-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:42:02Z","timestamp":1683114122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-005-1105-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":24,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1105"],"URL":"https:\/\/doi.org\/10.1007\/s00415-005-1105-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}